TWST: Where are you focusing your attention in the medical device space these days?
Mr. Denhoy: We continue to follow the space fairly broadly. We follow about 30 stocks, most concentrated in cardiovascular and orthopedics,

Raj Denhoy is a Managing Director in equity research at Jefferies & Company, Inc., out of New York City, focusing on the medical device sector. He has covered the device sector for more than 10 years and was previously a Senior Research Analyst at Thomas Weisel Partners, Bear Stearns and Piper Jaffray & Co... More
Published April 26, 2014 in Biotechnology and Pharmaceuticals
Buy ($75)"We’re a faith-based and socially responsible investing firm"
Published May 16, 2013 in Investing in Health Care
Buy ($75)"The fund is about $40 million in assets"
Published May 16, 2013 in Investing in Health Care
Buy ($75)Published May 14, 2013 in High-Yield Equity Securities
Buy ($75)Published May 16, 2013
Published May 10, 2013
Published May 10, 2013